Navigation Links
Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
Date:10/24/2011

NEW YORK, Oct. 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape

http://www.reportlinker.com/p0660750/Active-Pharmaceutical-Ingredients-APIs-in-the-Americas-Market-to-2016---Growth-in-Biotechnology-and-Generic-Segments-and-the-Pharmaceutical-Patent-Cliff-will-Shape-the-Landscape.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=IT_Hosting

Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape

Summary

GBI Research's report, "Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape" provides detailed insight into the American API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints, and competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the American API market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The API Market revenues in the Americas are expected to grow at a Compounded Annual Growth Rate (CAGR) of 4.7% from 2010 to 2015. As the North American pharmaceutical market recovers from the impacts of economic downturn, the API market revenues are expected to witness a steady growth. The faster growing markets of South and Central America will have greater contribution to the overall Americas API market growth. Brazil, especially, is witnessing very strong growth in pharmaceuticals and API market revenues and is expected to overtake Mexico in the coming years.

Scope

- Market revenue data for APIs from 2005 to 2010 and forecast for six years to 2016

- API markets in key countries in the region: the US, Canada, Mexico and Brazil

- API industry structure and market trends such as shift of market from branded to generic and rise of biotechnology in the American region

- Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and SWOT analysis of the API market for the region's key countries

- Information on the competitive landscape, with shares of leading companies such as Pfizer Inc., Astrazeneca International, GlaxoSmithKline Pharmaceuticals Ltd., Roche and Sanofi Aventis

- Analysis of API revenue based on product types in the American market and in key countries of the region.

- Analysis of API revenue based on therapeutic categories in the key countries.

Reasons to buy

- Develop business strategies with the help of specific insights on the American API market.

- Identify opportunities and challenges in the American API market.

- Invest in the growing segments of the API market.

- Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the American API market.

- Benchmark your operations and strategies against the major players in the global API market.

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 GBI Report Coverage 11

3 Americas API Market 12

3.1 Americas API Industry Structure 12

3.2 Americas API Industry Challenges 13

3.2.1 Economic Downturn has Restricted Investment in Pharmaceutical Industry 13

3.2.2 High Costs Hinder New Drug Development in the Region 13

3.2.3 Maturity of Synthetic APIs Hamper Profit Margin Growth 13

3.2.4 Regulatory Changes Lead to Delays in the Launch of New Drugs in the Market 13

3.2.5 Patent Expiries of Best Selling Drugs Threatens Revenue Growth 13

3.3 Americas API Industry Trends 13

3.3.1 Patent Expiries are Changing Pharmaceutical Market Dynamics in America 13

3.3.2 Specialty Driven Products are Expected to Play an Important Role in the American API Market 13

3.3.3 Outsourcing of API Manufacturing is Growing Fast in America 14

3.3.4 Mergers and Acquisitions (M&A) Activities have Increased Significantly in the American Pharmaceutical Industry 14

3.4 Americas API Market Revenue Analysis and Forecasts to 2016 15

3.5 Americas API Market Revenue Share Analysis by Product Type and Forecasts to 2016 17

3.5.1 Americas API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016 18

3.5.2 Americas API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016 19

3.6 Americas API Market Revenue Share Analysis by Country and Forecasts to 2016 20

3.7 North America API Market 21

3.7.1 North America API Market Overview 21

3.7.2 North America API Market Drivers 21

3.7.3 North America API Market Restraints 21

3.7.4 North America API Market Revenue Analysis and Forecasts to 2016 23

3.7.5 North America API Market Revenue Share Analysis by Product Type and Forecasts to 2016 25

3.7.6 North America API Market Revenue Share Analysis by Country and Forecasts to 2016 31

3.8 North America API Market Competitive Landscape 32

3.9 South and Central America API Market 34

3.9.1 South and Central America API Market Overview 34

3.9.2 South and Central America API Market Drivers 34

3.9.3 South and Central America API Market Restraints 35

3.9.4 South and Central America API Market Revenue Analysis and Forecasts to 2016 35

3.9.5 South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2016 37

3.9.6 South and Central America API Market Revenue Share Analysis by Country and Forecasts to 2016 43

3.9.7 South and Central America API Market Competitive Landscape 44

4 The US API Market 45

4.1 The US API Market Overview 45

4.2 The US API Market Drivers 45

4.2.1 The Rising Incidence of Lifestyle and Old Age Diseases is Giving Rise to API Demand in the Region 45

4.2.2 Growth in Oncology is One of the Major Contributing Factors to the Growth of APIs in the Region 45

4.2.3 Growth in Biotechnology will Favor Growth of API Market Revenues 45

4.2.4 Increasing Focus on High Potency APIs Helps Market Growth 45

4.3 The US API Market Restraints 45

4.3.1 The Economic Downturn has Restricted the Growth of API Demand in the US 45

4.3.2 Decreasing Focus on the Innovator Sector Limits the Growth of the US API Market 46

4.3.3 Patent Expiry of Some Blockbuster Molecules Will Adversely Affect the Growth of the API Market in the Region 46

4.3.4 Rising Competition from China and India is Creating Price Pressure in the US Market 46

4.4 The US API Market Revenue Analysis and Forecasts to 2015 46

4.5 The US API Market Revenue Share Analysis by Product Type and Forecasts to 2015 48

4.5.1 The US API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 48

4.5.2 The US API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 51

4.6 The US API Market Revenue Share Analysis by Therapeutic Category 54

4.7 The US API Market SWOT Analysis 55

4.7.1 Strengths 55

4.7.2 Weaknesses 55

4.7.3 Opportunities 56

4.7.4 Threats 56

5 Canada API Market 57

5.1 Canada API Market Overview 57

5.2 Canada API Market Drivers 57

5.2.1 Government Support for Increasing Healthcare Standards Encourages API Market Growth 57

5.2.2 Fast Growing Biotechnology Industry in the Country Increases Demand for APIs 57

5.2.3 Growth in Old Age Population in Canada Provides Leads to Growth of the API Market 57

5.3 Canada API Market Restraints 57

5.3.1 Patent Expiries of Some Blockbuster Drugs Will Negatively Impact the API Market 57

5.3.2 Price Controls by the Government Affects API Market Revenues 57

5.4 Canada API Market Revenue Analysis and Forecasts to 2015 58

5.5 Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2015 59

5.5.1 Canada API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 59

5.5.2 Canada API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 62

5.6 Canada API Market Revenue Share Analysis by Therapeutic Category 65

5.7 Canada API Market SWOT Analysis 66

5.7.1 Strengths 66

5.7.2 Weaknesses 66

5.7.3 Opportunities 67

5.7.4 Threats 67

6 Mexico API Market 68

6.1 Mexico API Market Overview 68

6.2 Mexico API Market Drivers 68

6.2.1 Strong Growth in Pharmaceutical Market Leads the API Market in Mexico 68

6.2.2 Rapid Growth in Generics Market Encouraging API Demand 68

6.3 Mexico API Market Restraints 68

6.3.1 Patent Expiries of Blockbuster Drugs will Negatively Impact Market Revenue Growth 68

6.3.2 The Problem of Counterfeits Challenging the Market 68

6.4 Mexico API Market Revenue Analysis and Forecasts to 2015 69

6.5 Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 2015 70

6.5.1 Mexico API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 70

6.5.2 Mexico API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 73

6.6 Mexico API Market Revenue Share Analysis by Therapeutic Category 76

6.7 Mexico API Market SWOT Analysis 77

6.7.1 Strengths 77

6.7.2 Weaknesses 77

6.7.3 Opportunities 78

6.7.4 Threats 78

7 Brazil API Market 79

7.1 Brazil API Market Overview 79

7.2 Brazil API Market Drivers 79

7.2.1 Strongly Growing Economy Gives Boost to the API Market 79

7.2.2 Increase in Old Age Population Gives Rise to APIs Demand 79

7.2.3 Rapidly Growing Demand for Generic Drugs will Drive the Country's API Market 79

7.3 Brazil API Market Restraints 79

7.3.1 Delay in Drug Approvals Hinders the Market Growth 79

7.3.2 The Dependency on Imports for Pharmaceutical Raw Materials Restricts Market Growth 79

7.4 Brazil API Market Revenue Analysis and Forecasts to 2015 80

7.5 Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 2015 81

7.5.1 Brazil API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 81

7.5.2 Brazil API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 84

7.6 Brazil API Market Revenue Share Analysis by Therapeutic Category 87

7.7 Brazil API Market SWOT Analysis 88

7.7.1 Strengths 88

7.7.2 Weaknesses 89

7.7.3 Opportunities 89

7.7.4 Threats 89

8 Appendix 90

8.1 Abbreviations 90

8.2 Methodology 90

8.2.1 Coverage 90

8.2.2 Secondary Research 91

8.2.3 Primary Research 91

8.2.4 Expert Panel Validation 91

8.3 Contact Us 91

8.4 About GBI Research 92

8.5 Disclaimer 92

1.1 List of Tables

Table 1: API Market, Americas, Revenues, $m, 2005-2016 16

Table 2: API Market, Americas, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 18

Table 3: API Market, Americas, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 19

Table 4: API Market, Americas, Revenue Share by Country, %, 2010 and 2016 20

Table 5: API Market, North America, Major Drugs to Lose Patent Protection, 2011 and 2012 22

Table 6: API Market, North America, Revenues, $m, 2005-2016 24

Table 7: API Market, North America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 25

Table 8: API Market, North America, Revenue by Product Type Based on Synthesis Route, $m, 2005- 2016 27

Table 9: API Market, North America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 28

Table 10: API Market, North America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 30

Table 11: API Market, North America, Revenue Share by Country, %, 2010 and 2016 31

Table 12: API Market, North America, Competitive Landscape, %, 2010 33

Table 13: API Market, South and Central America, Revenues, $m, 2005-2016 36

Table 14: API Market, South and Central America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 37

Table 15: API Market, South and Central America, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 39

Table 16: API Market, South and Central America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 40

Table 17: API Market, South and Central America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 42

Table 18: API Market, South and Central America, Revenue Share by Country, %, 2010 and 2016 43

Table 19: API Market, The US, Revenues, $m, 2005-2016 47

Table 20: API Market, The US, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 48

Table 21: API Market, The US, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 50

Table 22: API Market, The US, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 51

Table 23: API Market, The US, Revenue by Product Type Based on Customer Base, $m, 2005-2016 53

Table 24: API Market, The US, Revenue Share by Therapeutic Category, %, 2010 54

Table 25: API Market, Canada, Revenues, $m, 2005-2016 58

Table 26: API Market, Canada, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 59

Table 27: API Market, Canada, Revenue by Product Type Based on Synthesis Route, $m, 2010 and 2016 61

Table 28: API Market, Canada, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 62

Table 29: API Market, Canada, Revenue by Product Type Based on Customer Base, $m, 2005-2016 64

Table 30: API Market, Canada, Revenue Share by Therapeutic Category, %, 2010 65

Table 31: API Market, Mexico, Revenues, $m, 2005-2016 69

Table 32: API Market, Mexico, Revenue Share by Product Types Based on Synthesis Route, %, 2010 and 2016 70

Table 33: API Market, Mexico, Revenues by Product Types Based on Synthesis Route, $m, 2005-2016 72

Table 34: API Market, Mexico, Revenue Share by Product Types Based on Customer Base, %, 2010 and 2016 73

Table 35: API Market, Mexico, Revenue by Product Types Based on Customer Base, $m, 2005-2016 75

Table 36: API Market, Mexico, Revenue Share by Therapeutic Category, %, 2010 76

Table 37: API Market, Brazil, Revenues, $m, 2005-2016 80

Table 38: API Market, Brazil, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 81

Table 39: API Market, Brazil, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 83

Table 40: API Market, Brazil, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 84

Table 41: API Market, Brazil, Revenue by Product Type Based on Customer Base, $m, 2005-2016 86

Table 42: API Market, Brazil, Revenue Share by Therapeutic Category, %, 2010 87

1.2 List of Figures

Figure 1: API, Global, Industry Value Chain, 2010 12

Figure 2: API Market, Americas, Revenues, $m, 2005-2016 15

Figure 3: API Market, Americas, Product Type, 2010 17

Figure 4: API Market, Americas, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 18

Figure 5: API Market, Americas, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 19

Figure 6: API Market, Americas, Revenue Share by Country, %, 2010 and 2016 20

Figure 7: API Market, North America, Revenues, $m, 2005-2016 23

Figure 8: API Market, North America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 25

Figure 9: API Market, North America, Revenue by Product Type Based on Synthesis Route, $m, 2005- 2016 26

Figure 10: API Market, North America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 28

Figure 11: API Market, North America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 29

Figure 12: API Market, North America, Revenue Share by Country, %, 2010 and 2016 31

Figure 13: API Market, North America, Competitive Landscape, %, 2010 32

Figure 14: API Market, South and Central America, Revenues, $m, 2005-2016 35

Figure 15: API Market, South and Central America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 37

Figure 16: API Market, South and Central America, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 38

Figure 17: API Market, South and Central America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 40

Figure 18: API Market, South and Central America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 41

Figure 19: API Market, South and Central America, Revenue Share by Country, %, 2010 and 2016 43

Figure 20: API Market, The US, Revenues, $m, 2005-2016 46

Figure 21: API Market, The US, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 48

Figure 22: API Market, The US, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 49

Figure 23: API Market, The US, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 51

Figure 24: API Market, The US, Revenue by Product Type Based on Customer Base, $m, 2005-2016 52

Figure 25: API Market, The US, Revenue Share by Therapeutic Category, %, 2010 54

Figure 26: API Market, The US, SWOT, 2010 55

Figure 27: API Market, Canada, Revenues, $m, 2005-2016 58

Figure 28: API Market, Canada, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 59

Figure 29: API Market, Canada, Revenue by Product Type Based on Synthesis Route, $m, 2010 and 2016 60

Figure 30: API Market, Canada, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 62

Figure 31: API Market, Canada, Revenue by Product Type Based on Customer Base, $m, 2005-2016 63

Figure 32: API Market, Canada, Revenue Share by Therapeutic Category, %, 2010 65

Figure 33: API Market, Canada, SWOT, 2010 66

Figure 34: API Market, Mexico, Revenues, $m, 2005-2016 69

Figure 35: API Market, Mexico, Revenue Share by Product Types Based on Synthesis Route, %, 2010 and 2016 70

Figure 36: API Market, Mexico, Revenues by Product Types Based on Synthesis Route, $m, 2005-2016 71

Figure 37: API Market, Mexico, Revenue Share by Product Types Based on Customer Base, %, 2010 and 2016 73

Figure 38: API Market, Mexico, Revenue by Product Types Based on Customer Base, $m, 2005-2016 74

Figure 39: API Market, Mexico, Revenue Share by Therapeutic Category, %, 2010 76

Figure 40: API Market, Mexico, SWOT Analysis, 2010 77

Figure 41: API Market, Brazil, Revenues, $m, 2005-2016 80

Figure 42: API Market, Brazil, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 81

Figure 43: API Market, Brazil, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 82

Figure 44: API Market, Brazil, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 84

Figure 45: API Market, Brazil, Revenue by Product Type Based on Customer Base, $m, 2005-2016 85

Figure 46: API Market, Brazil, Revenue Share by Therapeutic Category, %, 2010 87

Figure 47: API Market, Brazil, SWOT Analysis, 2010 88

Companies Mentioned

To order this report:

IT Hosting Industry: Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape

IT Hosting Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
2. New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
3. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
4. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
5. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
6. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
7. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
8. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
9. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
10. Going Beyond Spa Day: Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits
11. Radioactive Seed Therapy Shows Significant Reduction in Lung Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):